3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Gliosarcoma
1
Glioblastoma
1
Interventions
pembrolizumab
79
Cyclophosphamide
57
Specimen Handling
53
Carboplatin
50
fludarabine
46
Nivolumab
42
Magnetic Resonance Spectroscopy
42
Gemcitabine
38
Biopsy
37
Bevacizumab
34
Dexamethasone
31
Paclitaxel
28
venetoclax
27
Docetaxel
27
Cisplatin
26
Injections
25
atezolizumab
24
Pemetrexed
23
Ipilimumab
22
Capecitabine
22
Temozolomide
20
Oxaliplatin
19
abemaciclib
18
Rituximab
18
Lenalidomide
18
Fulvestrant
18
Cetuximab
18
Azacitidine
17
Fluorouracil
16
Vincristine
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Sonication
×
90 days
×
Clear all
NCT04528680
2026-04-13
SC9/ABX
Northwestern University
Phase 1/2
Active not recruiting
57 enrolled